NCT01216293View on ClinicalTrials.gov

Effect of Dexlansoprazole on Bone Homeostasis

PHASE1CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

November 1, 2010

Primary Completion Date

August 1, 2014

Study Completion Date

February 1, 2015

Conditions
HomeostasisBone and Bones
Interventions
DRUG

Dexlansoprazole

Dexlansoprazole 60 mg capsules

DRUG

Esomeprazole

Esomeprazole 40 mg capsules

DRUG

Placebo

Placebo-matching capsules

Trial Locations (12)

Unknown

San Diego

Walnut Creek

Lakewood

Hialeah

Jupiter

Bethesda

Albuquerque

Spartanburg

Austin

San Antonio

Seattle

Madison

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY